Comparison of CHOKAI vs STONE Score to Predict the Presence of Ureteric Stones in Patients With Renal Colic: A Multi-center Prospective Observational Study
A Multi-center Prospective Observational Study to Evaluate and Compare Diagnostic Accuracy and Reliability of Variables of the CHOKAI and STONE Scores to Predict the Presence of Ureteric Stones as Confirmed on CT Scans
1 other identifier
observational
92
1 country
3
Brief Summary
Background: The STONE score has traditionally been used as a clinical prediction tool to predict the presence of ureteric stones in patients presenting with renal colic. More recently, the CHOKAI score was introduced and found to have superior diagnostic accuracy on both internal and external validation. Objective: Our study aims to externally validate and compare the use of both the CHOKAI and STONE score in a population of UAE patients presenting to the Emergency Department for renal colic. Methods: Over a period of approximately 6 months, the study will follow Emergency Department Physicians at each institution and retrieve data from their encounters with patients presenting with renal colic. Parameters for both CHOKAI and STONE scores will be logged, extracted and matched against a reference standard of CT scan to compare diagnostic accuracy of both scores to predict the presence of ureteric stones in this population. Goals: Evaluation of the findings will discern applicability of scores to the UAE population and contribute to reducing unnecessary radiation exposure. To our knowledge, no studies have compared the use of these scores to diagnose urolithiasis in the United Arab Emirates. Furthermore, this will be the first study to externally validate the CHOKAI score outside of Japan using a controlled, prospective design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 3, 2021
CompletedFirst Posted
Study publicly available on registry
February 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2024
CompletedJuly 29, 2024
July 1, 2024
1.2 years
February 3, 2021
July 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy comparison
Compare the diagnostic accuracies of the CHOKAI and STONE scores in predicting the presence of ureteric stones by using differences in the area under the curve (AUC) between the CHOKAI and STONE scores, calculated using Receiver Operating Characteristic (ROC) analysis
6 months
Secondary Outcomes (2)
Determine optimal cut-off point
6 months
Rate of admission for patients
6 months
Eligibility Criteria
Adult patients presenting to the Emergency Department with symptoms suspicious of urolithiasis
You may qualify if:
- Adult population (≥18 years of age) presenting to the Emergency Department with symptoms determined by the investigating ED Physician to be suspicious of urolithiasis (e.g. flank pain, lower abdominal pain, back pain and/or hematuria)
- Patients suspected to have ureteric stone who underwent CT scan to confirm diagnosis
You may not qualify if:
- Complicated ureteric colic:
- Abnormal vital signs - body temperature \> 37.7 °C or systolic blood pressure ˂90 mmHg)
- Active malignancy
- Abnormal kidney function (abnormal levels of creatinine/BUN)
- Recent (within past 6 months) trauma or urologic surgery
- Age \<18 years
- Pregnant patient
- Patient with incomplete interview/documentation data (e.g. missing US/CT/ UA)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Sheikh Shakhbout Medical City
Abu Dhabi, United Arab Emirates
Tawam Hospital
Abu Dhabi, United Arab Emirates
Zayed Military Hospital
Abu Dhabi, United Arab Emirates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Anzal Rehman, MD
Zayed Military Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Emergency Medicine Resident
Study Record Dates
First Submitted
February 3, 2021
First Posted
February 18, 2021
Study Start
February 1, 2021
Primary Completion
March 31, 2022
Study Completion
July 25, 2024
Last Updated
July 29, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Protocol and Informed Consent data will be available for 6 months from study start date Study Analysis Plan (SAP) will be available for 3 months once data collection is completed and results compiled for analysis
- Access Criteria
- Any interested researcher can approach the Principal Investigator, Mohammad Anzal Rehman, at chokai.study@outlook.com for any of the details listed above within the time frames mentioned for access to the same.
The protocol for selection of patients used for prospective data collection shall be made available for the entirety of the study duration, including the Informed Consent Form we will use during patient encounters. The Statistical Analysis Plan (SAP) will be shared after results are compiled (approximately in 6 months from study start date) and processed by the biostatistician for a period of 3 months